Stephen Trevisan

Mr. Trevisan is an entrepreneur who has founded five life-sciences companies, including Accelovance, Inc., a niche Contract Research Organization (CRO) focused primarily in oncology, vaccines, and general medicine, where he served as Chairman, President and CEO.  Prior to Accelovance, Mr. Trevisan founded TherImmune Research Corporation, a CRO specializing in preclinical and early-stage clinical drug development services for the pharmaceutical, biotechnology, and government markets. He also founded CommSys Corporation, a provider of outsourced billing services to the telecommunications industry. In 1987, Mr. Trevisan co-founded his first company, National Clinical Research Centers (NCRC), a CRO specializing in Phase II-IV clinical studies. NCRC deployed a unique method for running clinical trials which was successful in reducing the timeframe in conducting multi-center trials in broad-based indications. Each of Mr. Trevisan's prior companies maintained year-over-year growth and were ultimately acquired by public companies.